FDA panel votes to remove serious warning from Chantix label

Stephen Feller
WASHINGTON, Sept. 15 (UPI) -- An advisory panel at the FDA voted to recommend the removal of a black box warning for psychological side effects of the drug smoking cessation drug Chantix.